Supplemental Ascorbate, Vitamin C, in the Supportive Treatment of Cancer
A study was made of the survival times of 100 terminal cancer patients who were given supplemental ascorbate, Vitamin C, as part of their routine management and 1000 matched controls, similar patients who had received the same treatment except for the ascorbate. The object of the investigation was to determine whether supplemental ascorbate prolongs the survival times of patients with terminal human cancer.
KeywordsSurvival Time Matched Control Supportive Treatment Short Survival Time District General Hospital
Unable to display preview. Download preview PDF.